Hartford Investment Management Co (HIMCO)’s United Therapeutics UTHR Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,793	Closed	-$644K	–	561
2020 Q1	$644K	Sell	6,793 -1,257	-16%	-$119K	0.02%	463
2019 Q4	$709K	Hold	8,050	–	–	0.02%	507
2019 Q3	$642K	Buy	+8,050	New	+$648K	0.02%	510
2015 Q3	–	Sell	-1,190	Closed	-$207K	–	647
2015 Q2	$207K	Buy	+1,190	New	+$214K	﹤0.01%	607
2014 Q4	–	Sell	-1,598	Closed	-$206K	–	722
2014 Q3	$206K	Buy	+1,598	New	+$165K	﹤0.01%	704

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s UTHR Position: Q2 2020 in Review

Hartford Investment Management Co (HIMCO) sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 6,793 shares — an estimated $644K sold.

Hartford Investment Management Co (HIMCO) first reported a position in UTHR in Q3 2014 and held it in 5 quarters. The position peaked at $709K in Q4 2019. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

Hartford Investment Management Co (HIMCO) reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
Hartford Investment Management Co (HIMCO) sold 6,793 United Therapeutics shares in Q2 2020, an estimated $644K.
Hartford Investment Management Co (HIMCO) first reported a position in United Therapeutics in Q3 2014 and held it in 5 quarters.
Hartford Investment Management Co (HIMCO)'s United Therapeutics position peaked at $709K in Q4 2019.
349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2020, filed 4 Aug 2020.